title: Can rechallenge be done safely after mild or moderate drug-induced liver injury?
authors.affiliation: Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration (FDA), Department of Health and Human Services, Silver Spring, MD.
authors.forename: John R
authors.initials: JR
authors.lastname: Senior
mesh_terms: D056486:Chemical and Drug Induced Liver Injury; D018849:Controlled Clinical Trials as Topic; D006801:Humans